This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Duda, D. G. Articles by Jain, R. K. Search for Related Content PubMed PubMed Citation Articles by Duda, D. G. Articles by Jain, R. K.

Differential Transplantability of Tumor-Associated Stromal Cells

E. L. Steele Laboratory for Tumor Biology, Departments of Radiation Oncology and Molecular Biology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts

At the time of transplantation, tumor fragments contain "passenger" cells: endothelial cells and other stromal cells from the original host. Here, we investigated the fate of genetically labeled endothelial and nonendothelial stromal cells after transplantation in syngeneic mice. We report that angiogenic stroma associated with tumor or adipose tissue persists when transplanted, remains functional, and governs the initial neovascularization of grafted tissue fragments for more than 4 weeks after implantation. Surprisingly, the passenger endothelial cells survive longer than other stromal cells, which are replaced by host-activated fibroblasts after 3 weeks. The transplantability of tumor stroma suggests that the angiogenic potential of a tumor xenograft, which determines its viability, depends on the presence of passenger endothelial cells and other stromal cells within the xenograft. These studies of tumor tissue transplantation provide a platform for exploring the role of epithelial–stromal interactions in studies of tumor heterogeneity and drug resistance.

This article has been cited by other articles:

				S. Bruno, B. Bussolati, C. Grange, F. Collino, M. E. Graziano, U. Ferrando, and G. Camussi CD133+ Renal Progenitor Cells Contribute to Tumor Angiogenesis Am. J. Pathol., December 1, 2006; 169(6): 2223 - 2235. [Abstract] [Full Text] [PDF]

				D. G. Duda, K. S. Cohen, S. V. Kozin, J. Y. Perentes, D. Fukumura, D. T. Scadden, and R. K. Jain Evidence for incorporation of bone marrow-derived endothelial cells into perfused blood vessels in tumors Blood, April 1, 2006; 107(7): 2774 - 2776. [Abstract] [Full Text] [PDF]

				S.-C. Hung, W.-P. Deng, W. K. Yang, R.-S. Liu, C.-C. Lee, T.-C. Su, R.-J. Lin, D.-M. Yang, C.-W. Chang, W.-H. Chen, et al. Mesenchymal Stem Cell Targeting of Microscopic Tumors and Tumor Stroma Development Monitored by Noninvasive In vivo Positron Emission Tomography Imaging Clin. Cancer Res., November 1, 2005; 11(21): 7749 - 7756. [Abstract] [Full Text] [PDF]

				M. Yang, J. Reynoso, P. Jiang, L. Li, A. R. Moossa, and R. M. Hoffman Transgenic Nude Mouse with Ubiquitous Green Fluorescent Protein Expression as a Host for Human Tumors Cancer Res., December 1, 2004; 64(23): 8651 - 8656. [Abstract] [Full Text] [PDF]